Citation Impact
Citing Papers
Current therapy for malignant mesothelioma
2002
The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review
2005
The Oslo definitions for coeliac disease and related terms
2012 Standout
American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease
2006
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Celiac Disease
2007 Standout
Irritable bowel syndrome
2016 Standout
Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports
2006
Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl‐2 and Bcl‐xL antisense treatment
2003
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Pyroptosis: A new frontier in cancer
2019 Standout
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
2018 Standout
Clinical Benefit of a Gluten-Free Diet in Type 1 Diabetic Children With Screening-Detected Celiac Disease
2006 StandoutNobel
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Haplotype Analysis Discriminates Genetic Risk for DR3-Associated Endocrine Autoimmunity and Helps Define Extreme Risk for Addison’s Disease
2010
Endocrinological Disorders and Celiac Disease
2002
Works of Jonas Weyler being referenced
Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium
1994
Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes
2001
Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium
1994